"10.1371_journal.pone.0022318","plos one","2011-07-22T00:00:00Z","Lutz P Breitling; Wolfgang Koenig; Marcus Fischer; Ziad Mallat; Christian Hengstenberg; Dietrich Rothenbacher; Hermann Brenner","Division C070 Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Internal Medicine II-Cardiology, University of Ulm Medical Center, Ulm, Germany; Klinik und Poliklinik für Innere Medizin II, University of Regensburg, Regensburg, Germany; Division of Cardiovascular Medicine, Addenbrooke's Hospital, Cambridge, United Kingdom; Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany","Conceived and designed the experiments: WK CH DR HB. Performed the experiments: WK MF ZM CH DR HB. Analyzed the data: LB. Wrote the paper: LB. Manuscript revision: WK MF ZM CH DR HB.","ZM is listed as coinventor on a patent related to the use of sPLA2 as a cardiovascular biomarker. (The patent is not granted yet. Reference: Mallat Z, Benessiano J, Tedgui A. Use of sPLA2 activity for the diagnostic of cardiovascular events. European Patent Application n° 06 291 238.1 filed on 31/07/06 by Inserm). WK is the National Coordinator and member of the steering committee for the VISTA-16 trial and a consultant to Anthera. The other authors report no conflict of interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","07","Lutz P Breitling","LPB",7,TRUE,4,6,1,1,TRUE,TRUE,FALSE,0,NA,FALSE
